Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
88.76 EUR | -1.22% | -1.38% | -1.11% |
01:07pm | EU okays $1.5 bln state funded joint hydrogen project, $1.1 bln joint healthcare project | RE |
May. 27 | Sanofi Gets US FDA’s Priority Review for Expanded Use of Blood Cancer Drug Sarclisa | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.11% | 122B | |
+38.51% | 727B | |
+31.67% | 594B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+14.51% | 243B | |
+7.42% | 205B | |
-6.22% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- SAN Stock
- News Sanofi
- Regeneron Pharmaceuticals, Sanofi Say FDA Accepts Dupixent Supplemental Application for Priority Review